Madrigal Pharmaceuticals Alternatives & Competitors
12 companies similar to Madrigal Pharmaceuticals — Madrigal is focused on delivering novel therapeutics for MASH, a serious liver d...
Companies similar to Madrigal Pharmaceuticals
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-...
San Francisco, United Sta...
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. is not affiliated in any way with Wire™ or Wire Swiss GmbH in...
Edison, United States
Track all Madrigal Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ocera Therapeutics
Dedicated to Innovation in Liver Disease Treatment, Pioneering Life-Saving Therapeutics fo...
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
Palo Alto, United States
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
France
Humedics GmbH
Quantifying functional liver capacity
Berlin, Germany
HighTide Therapeutics
East Meets West—The Quest for Cure
Shenzhen, China
Amarin Corporation
Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve c...
Inversago Pharma
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrot...
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company founded in 2016, focusing on developing therapeutics for metabolic and fatty liver diseases. The company's first therapy received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adults with nonalcoholic steatohepatitis (N...
Biopharmaceutical, Therapeutics, Metabolic Diseases, Liver Disease, NASH Treatment, Cardiovascular-metabolic Diseases, Diabetes Treatment, Dyslipidemia Treatment, Clinical-stage Biopharmaceutical Company, Accelerated Approval, Phase 3 Trial, Nonalcoholic Steatohepatitis, Compensated Cirrhosis, Liver Fibrosis, FDA Approval
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Madrigal Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Madrigal Pharmaceuticals on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
